Most people assume that if something serious were developing in the body, a routine blood test would flag it — the same way a basic panel catches high cholesterol or elevated blood sugar. When it comes to breast cancer, that assumption feels reasonable. It's also, for the most part, incorrect.
Blood work does have a real role in breast cancer care. It just shows up at different points than most people expect: after a diagnosis, during treatment, and in specific high-risk situations — rather than as the first line of detection. During Breast Cancer Awareness Month, here's where blood tests genuinely help, and where imaging and tissue biopsy remain irreplaceable.
Can a Blood Test Diagnose Breast Cancer?
No single blood test can diagnose breast cancer. The gold standard for finding it remains the mammogram, paired with a clinical exam and, when something suspicious appears, a tissue biopsy. Blood tests can support that picture in specific situations, but they don't replace imaging.
Screening guidance has also shifted recently: the U.S. Preventive Services Task Force now recommends that women at average risk begin mammograms at age 40 and continue every two years through age 74, a change from the previous starting age of 50. Anyone with a family history or other risk factors should talk with their provider about starting earlier.
What Do Tumor Marker Blood Tests Like CA 15-3 Measure?
Tumor marker tests such as CA 15-3 and CA 27.29 measure proteins that some breast cancer cells release into the bloodstream. They're used almost exclusively to monitor people already diagnosed with breast cancer — tracking how well treatment is working or watching for recurrence — not to screen someone without symptoms.
That's because these markers aren't reliable enough to catch cancer early. Levels are elevated in fewer than half of women with early-stage, localized breast cancer, and they can also rise with benign breast conditions or unrelated illnesses. A normal result doesn't rule out cancer, and an elevated one doesn't confirm it.
Can a Blood Test Reveal Genetic Risk for Breast Cancer?
Genetic blood testing for mutations in genes like BRCA1 and BRCA2 can show whether someone carries an inherited mutation that raises their lifetime risk of breast cancer. It's a risk assessment, not a cancer test — a positive result means increased risk, not a current diagnosis.
Current guidelines recommend this testing for people with a strong family history, and for anyone diagnosed with breast cancer at age 50 or younger. It's worth noting that most people with a family history of breast cancer do not carry a BRCA mutation, which is why genetic counseling — not the blood draw itself — is usually the recommended first step.
What Is Liquid Biopsy, and Could It Replace Mammograms?
Liquid biopsy is a newer blood test that looks for fragments of tumor DNA (ctDNA) or circulating tumor cells shed into the bloodstream. Today, it's used mainly to monitor people already diagnosed with breast cancer — tracking treatment response, watching for resistance mutations, and sometimes flagging recurrence before it would show up on a scan.
It is not yet a population screening tool. In early-stage disease, tumor DNA is often present in such small amounts that current tests struggle to detect it reliably. Researchers are actively working on this, but for now, liquid biopsy is a monitoring tool for known cancer — not a mammogram replacement.
What Blood Tests Happen During Breast Cancer Treatment?
Once someone is diagnosed, blood work becomes a regular part of care — just for a different reason. A complete blood count (CBC) is commonly checked before and during chemotherapy, since these drugs can reduce red blood cells, white blood cells, and platelets by affecting the fast-dividing cells in bone marrow along with cancer cells. Low counts raise the risk of infection, fatigue, and bleeding, so care teams monitor them closely and may adjust treatment timing or dosing in response.
Tracking Your Blood Health Beyond the Clinic
Awareness Month understandably centers on screening reminders — and it should. It's also a reasonable moment to think about blood health more broadly between appointments. The Ruby app estimates an Iron Score and a Circulation Score from a simple fingernail selfie, helping people track general wellness patterns over time.
To be clear: Ruby does not screen for, detect, or monitor breast cancer in any way. It's a wellness companion for iron and circulation trends, not a diagnostic tool. Download Ruby on iOS or Android to start tracking your own patterns.
If you notice a new lump, skin changes, nipple discharge, or any other breast change, contact your healthcare provider promptly rather than waiting for your next scheduled screening. And always talk with a qualified healthcare provider about which tests — blood-based or otherwise — make sense for your individual risk.
Common FAQs
- Can a blood test detect breast cancer?
Not on its own. Imaging (mammogram) and tissue biopsy remain the only ways to diagnose breast cancer; blood tests play a supporting role in specific situations, mainly after diagnosis. - What is a CA 15-3 blood test used for?
It measures a protein some breast cancer cells release, mainly used to monitor treatment response and watch for recurrence in people already diagnosed — not to screen the general population. - Who should consider BRCA genetic testing?
People with a strong family history of breast or ovarian cancer, and anyone diagnosed with breast cancer at 50 or younger, per current guidelines. A genetic counselor can help determine if testing makes sense. - Is liquid biopsy used to screen for breast cancer?
Not yet for the general population. It's currently used mainly to monitor known breast cancer — tracking treatment response and watching for recurrence. - What blood tests happen during breast cancer treatment?
A complete blood count is commonly checked throughout chemotherapy to monitor red blood cells, white blood cells, and platelets, since treatment can temporarily lower all three.
References
1. U.S. Preventive Services Task Force — Breast Cancer: Screening (2024 Final Recommendation Statement): https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening
2. Breastcancer.org — Mammogram Screening Recommendations: https://www.breastcancer.org/screening-testing/mammograms/recommendations
3. Testing.com — The CA 15-3 Test: Purpose and Results: https://www.testing.com/tests/ca-15-3/
4. Breastcancer.org — Genetic Testing for Breast Cancer: What It Is and What to Expect: https://www.breastcancer.org/genetic-testing
5. Nature, Signal Transduction and Targeted Therapy — Liquid Biopsy in Cancer: Current Status, Challenges and Future Directions: https://www.nature.com/articles/s41392-024-02021-w
6. Baylor College of Medicine — Chemotherapy: Effect on Blood Cells: https://www.bcm.edu/healthcare/specialties/oncology/cancer-treatment/chemotherapy
Leave a comment
All comments are moderated before being published.
This site is protected by hCaptcha and the hCaptcha Privacy Policy and Terms of Service apply.